Since miR-34a expression is downregulated in lung cancer patients [31], lncRNA Sirt1-AS may block the miR-34a-binding site on Sirt1, thereby inhibiting EMT in lung cancer. The gene discussed is SIRT1; the disease is lung carcinoma.